BSE filing, NSE: SAMRATPH. Summary written from the filing by ALFA Finder's alert engine.
Samrat Pharmachem Ltd: key numbers
- Share price
- ₹261.10
- Market cap
- ₹80.67 Cr
- Revenue (annual)
- ₹289.7 Cr
- Net profit (annual)
- ₹-3.31 Cr
- P/E (TTM)
- -36.5×Sector 48.7×
- Promoter holding
- 49.09%+0.00% QoQ
- FII holding
- 3.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Samrat Pharmachem Ltd
All →Samrat Pharmachem Other Announcement
Samrat Pharmachem Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations. This is a routine compliance disclosure detailing the company's ownership structure.
Samrat Pharmachem Board Meeting Date
Samrat Pharmachem will hold a board meeting on November 14, 2026, to consider its unaudited quarterly financial results for the period ended September 2026.
Samrat Pharmachem Other Announcement
Samrat Pharmachem Limited appointed M/s Divyesh J Shah & Associates as Statutory Auditors following the expiry of the previous auditor's tenure at the 34th Annual General Meeting.
Samrat Pharmachem Annual General Meeting
Samrat Pharmachem Limited held its 34th Annual General Meeting on September 23, 2026. The meeting successfully transacted the business items outlined in the prior meeting notice.
Samrat Pharmachem Annual General Meeting
Samrat Pharmachem will hold its 34th Annual General Meeting on September 23, 2026, via video conferencing. The company also announced book closure dates for shareholders.
Samrat Pharmachem Annual Report
Samrat Pharmachem filed its 34th Annual Report for FY 2025-26. The company's 34th AGM is scheduled for September 23, 2026, via video conferencing.
Other other announcement announcements
All →Bulkcorp International Other Announcement
Bulkcorp International filed a non-applicability intimation stating corporate governance provisions do not apply to the company as an SME-listed entity. No business event or transaction is reported.
Indus Finance Other Announcement
Indus Finance Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoters and promoter group hold 74.79%, with the balance held by public shareholders.
HMA Agro Industries Other Announcement
HMA Agro Industries' shareholding pattern shows promoters holding 75.00% as of 7 August 2026. The routine Regulation 31 filing records no transaction or corporate action.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital's quarterly shareholding pattern shows promoters holding 57.10%. The routine filing reports no corporate action or event value.
Accretion Nutraveda Other Announcement
Accretion Nutraveda's quarterly shareholding pattern shows promoters holding 73.48%. The routine filing reports no corporate action or event value.
Godrej Industries Other Announcement
Godrej Industries notified shareholders about SEBI's special window for re-lodgement and dematerialization of physical shares. The window runs February 2026 to February 2027 for pre-2019 transactions.